SHPH Stock Analysis: Buy, Sell, or Hold?
SHPH - Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$4.58
0.35 (8.27%)
▲
5d:
+4.57%
30d:
+25.48%
90d:
+545.07%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When SHPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SHPH is 11.7% above its trading range ($4.10). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SHPH is 11.7% above its trading range ($4.10). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SHPH is currently trading at $4.58, which is considered extended relative to its 30-day fair value range of $2.96 to $4.10.
Technical Outlook: Technically, SHPH is in a strong uptrend. Immediate support is located at $2.92, while resistance sits at $4.80. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: SHPH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SHPH is in a strong uptrend. Immediate support is located at $2.92, while resistance sits at $4.80. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: SHPH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.96 -
$4.10
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
11.8%
All Signals
- BEARISH: Price significantly overextended (+11.7% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.96 -
$4.10
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.92
Resistance Level
$4.80
Current Trend
Strong Uptrend
Technical data as of
Aug 13, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 13, 2026 11:07 PM ET
Data refreshes hourly during market hours. Next update: 12:07 AM
Data refreshes hourly during market hours. Next update: 12:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SHPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$213 | 47 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$108 | 46 HOLD |
|
ALKS
Alkermes Plc |
BUY
15 analysts |
$56 | 67 BUY |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 63 BUY |
